Association between Insomnia and Chronic Noncommunicable Diseases: Current findings and future directions
International Journal of Development Research
Association between Insomnia and Chronic Noncommunicable Diseases: Current findings and future directions
Received 20th June, 2017; Received in revised form 17th July, 2017; Accepted 24th August, 2017; Published online 30th September, 2017
Copyright ©2017, Lígia Aurélio Bezerra Maranhão Mendonça et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Insomnia is a sleep disorder that consistently interferes with the quantity and quality of sleep. It is a condition responsible for the development of neuro-endocrine metabolic changes connected to an increased risk of developing noncommunicable chronic diseases. Thus, changes in the neuro-endocrine metabolic axis due to insomnia lead to an increase or decrease in the synthesis and/or secretion of hormones, which is directly associated with important changes in glucose, lipid and protein metabolism, resulting in a physiological and metabolic condition as an alternative to the resumption of homeostasis. This condition, when chronic, allows the development of metabolic diseases such as cardiovascular diseases, diabetes mellitus type 2, systemic arterial hypertension, hypercholesterolemia, among others which have become endemic in modern society.
